Inogen Inc (INGN)

9.72 +0.35 (+3.74%) USD  |  NASDAQ  |  Jan 08, 16:00
8.90 -0.82 (-8.44%) After-Hours: 04:39
More

Inogen Research and Development Expense (Annual): 20.84M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for INGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Globus Medical Inc 124.01M
Glaukos Corp 138.77M
Emergent BioSolutions Inc 111.40M
Marinus Pharmaceuticals Inc 99.39M
Rocket Pharmaceuticals Inc 186.34M